| Literature DB >> 32714172 |
Jan-Patrick Stellmann1,2,3,4, Adil Maarouf3,4, Karl-Heinz Schulz5,6, Lisa Baquet1,2, Jana Pöttgen1,2, Stefan Patra5,6, Iris-Katharina Penner7, Susanne Gellißen1,8, Gesche Ketels9, Pierre Besson3,4, Jean-Philippe Ranjeva3,4, Maxime Guye3,4, Guido Nolte10, Andreas K Engel10, Bertrand Audoin3,4, Christoph Heesen1,2, Stefan M Gold1,11,12.
Abstract
Objectives: Evidence from animal studies suggests that aerobic exercise may promote neuroplasticity and could, therefore, provide therapeutic benefits for neurological diseases such as multiple sclerosis (MS). However, the effects of exercise in human CNS disorders on the topology of brain networks, which might serve as an outcome at the interface between biology and clinical performance, remain poorly understood.Entities:
Keywords: CNS networks; exercise; multiple sclerosis; neuroplasticity; randomized controlled trial
Year: 2020 PMID: 32714172 PMCID: PMC7340166 DOI: 10.3389/fnhum.2020.00255
Source DB: PubMed Journal: Front Hum Neurosci ISSN: 1662-5161 Impact factor: 3.169
Descriptive statistics.
| Waiting group | Exercise group | Healthy controls | |||
|---|---|---|---|---|---|
| Females | 21 (77.8) | 18 (60.0) | 0.248§ | 20 (66.7) | 0.353 |
| Age years | 40.0 (9.8) | 38.3 (10.1) | 0.530# | 40.6 (8.7) | 0.477 |
| Disease duration years | 5.3 (6.3) | 6.1 (5.5) | 0.646# | ||
| Right handed | 25 (93.0) | 28 (93.3) | 0.259§ | 28 (93.3) | 1.000 |
| Education >12 years | 21 (77.8) | 24 (80.0) | 0.897§ | 19 (63.3) | 0.055 |
| Non smokers | 17 (63.0) | 24 (80.0) | 0.305§ | 24 (80.0) | 0.293 |
| Immunotherapy | 11 (40.7) | 19 (63.3) | 0.150§ | ||
| Disability | |||||
| EDSS median (range) | 1.5 (0–3.5) | 1.5 (0–3.5) | 0.574§ | ||
| SDMT correct answers | 58.0 (9.9) | 60.0 (11.8) | 0.491# | ||
| T25FW seconds | 4.8 (0.8) | 4.6 (0.8) | 0.434# | ||
| 6MWT meters | 437 (78) | 441 (107) | 0.851# | ||
| FSMC score | 49.4 (22.0) | 49.3 (21.1) | 0.990# | ||
| HADS Depression score | 3.6 (3.6) | 3.5 (3.3) | 0.949# | ||
| Fitness | |||||
| Weight kg | 68.1 (10.6) | 80.5 (19.9) | 0.005# | ||
| VO2-peak ml kg−1 min−1 | 25.4 (5.2) | 28.5 (7.5) | 0.078# | ||
| Training sessions median (range) | 0 | 22 (10–36) |
EDSS, Expanded Disability Status Scale (Global disability, range 0–10); SDMT, Symbol Digit Modality Test (Cognition); T25FW, Timed 25 Foot Walk (Mobility); 6MWT, 6-Minute Walking Test (Mobility); FSMC, Fatigue Scale for Motor and Cognitive Functions; HADS, Hospital Anxiety and Depression Scale; Data as mean (sd) if not otherwise indicated, § = Chi-Square-Test, # = Student’s t-Test.
Figure 1Reorganization of functional connectivity. Reorganization of functional connectivity based on the adapted hub disruption index. (A) Baseline: the mean degree of nodes from controls is plotted against the difference between mean baseline values from patients and controls. (B) Mean differences from baseline to month 3 (Δ0–3) in both patient groups are plotted against mean values from healthy controls. (C) Changes of a degree from baseline, node size indicates absolute change while the color indicates the direction.
Figure 2Reorganization of structural connectivity. Reorganization of structural connectivity based on the adapted hub disruption index. (A) Baseline: the mean strength of nodes from controls is plotted against the difference between mean baseline values from patients and controls. (B) Mean differences from baseline to month 3 (Δ0–3) in both patient groups are plotted against mean values from healthy controls. (C) Changes of strength from baseline, node size indicates absolute change while the color indicates the direction.
Figure 3Clustering of nodes in structural networks: Baseline and changes. Nodal clustering in structural networks analyzed with the adapted hub disruption index. (A) Baseline: mean differences of the clustering coefficient between patients and controls plotted vs. strength of the nodes as an indicator of the hubness. (B) Mean differences from baseline to month 3 (Δ0–3) are plotted against mean strength from healthy controls for both patient groups. (C) Changes of clustering from baseline, node size indicates absolute change while the color indicates the direction.
Figure 4Association between graph metrics and clinical scores. Baseline correlations between clinical outcomes and global network metrics (top, A), respectively individual hub disruption (bottom, B). Bright colors indicate p-values < 0.05, asterisks indicate p-values below 0.05 after FDR correction. EDSS, expanded disability status scale; SDMT, symbol digit modality test; VLMT, Verbal learning and memory test; Digit_bw, digit span backward; Digit_fw, digit span forward; TA, tonic alertness; PA, phasic alertness; PASAT, Paced Auditory Serial Addition Test; T25FW = timed 25 foot walk; 6MWT, 6-Minute-Walking-Test; VO2max/kg, VO2 max per kg body weight.